Status:
RECRUITING
Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates
Lead Sponsor:
University of Liege
Collaborating Sponsors:
University Hospital, Ghent
Free University of Brussels
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18-80 years
Brief Summary
Hepatocellular carcinoma (HCC) is a rising public health concern with few curative options but liver transplantion (LT) in highly selected cases. LT could save many other HCC patients but organ shorta...
Detailed Description
All adult patients (\> 18 and \< 80 years) suffering from HCC and discussed for potential deceased or living related LT during multidisciplinary oncologic meetings in the 6 Belgian LT centres will be ...
Eligibility Criteria
Inclusion
- HepatoCellular Carcinoma
- Liver transplant candidate after multidisciplinary disccuss
Exclusion
- Patients \< 18y or \> 80yr old
- Patients considered contra-indicated (CI) for LT due to non-liver-related medical problems (age, other cancer, psychiatric disease, uncontrolled infection, no compliance, active alcohol abuse, cardiac CI, pulmonary CI, surgical CI, other medical CI);
- Patients contra-indicated for LT due to the HCC: extra-hepatic metastases (M+), lymphatic involvement (N+), macro-vascular invasion.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2029
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT05276037
Start Date
January 1 2019
End Date
January 1 2029
Last Update
September 1 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Antwerp
Antwerp, Belgium
2
Free University of Brussels
Brussels, Belgium
3
University Hospital, Ghent
Ghent, Belgium
4
Catholic University of Louvain
Leuven, Belgium